Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an options trading signal again: unusual options activity screeners and strategies. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Enochian Biosciences Inc (ENOB)

Enochian Biosciences Inc (ENOB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 142,436
  • Shares Outstanding, K 52,950
  • Annual Sales, $ 0 K
  • Annual Income, $ -26,720 K
  • 60-Month Beta 1.03
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.88
Trade ENOB with:

Options Overview Details

View History
  • Implied Volatility 612.03% ( +89.46%)
  • Historical Volatility 129.21%
  • IV Percentile 100%
  • IV Rank 100.00%
  • IV High 612.03% on 08/11/22
  • IV Low 82.59% on 02/11/22
  • Put/Call Vol Ratio 1.30
  • Today's Volume 85
  • Volume Avg (30-Day) 111
  • Put/Call OI Ratio 1.58
  • Today's Open Interest 3,863
  • Open Int (30-Day) 4,616

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.84 +45.11%
on 07/12/22
2.99 -10.70%
on 08/08/22
+0.73 (+37.63%)
since 07/11/22
3-Month
1.42 +88.03%
on 07/05/22
7.04 -62.07%
on 05/13/22
-3.09 (-53.65%)
since 05/11/22
52-Week
1.42 +88.03%
on 07/05/22
13.78 -80.62%
on 12/01/21
-3.35 (-55.65%)
since 08/11/21

Most Recent Stories

More News
ENOB Investors Have Opportunity to Lead Enochian Biosciences, Inc. Securities Fraud Lawsuit

/PRNewswire/ -- Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action...

ENOB : 2.67 (-0.74%)
ENOB LAWSUIT ALERT: Levi & Korsinsky Notifies Enochian BioSciences, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

/PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Enochian BioSciences, Inc. ("Enochian" or the "Company") (NASDAQ: ENOB) of a class action...

ENOB : 2.67 (-0.74%)
ENOB ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 26, 2022 in the Class Action Filed on Behalf of Enochian BioSciences, Inc. Shareholders

/PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Enochian BioSciences, Inc. (NASDAQ:...

ENOB : 2.67 (-0.74%)
SHAREHOLER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Enochian Biosciences Inc. of Class Action Lawsuit and Upcoming Deadline - ENOB

/PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Enochian Biosciences Inc. ("Enochian" or the "Company") (NASDAQ:...

ENOB : 2.67 (-0.74%)
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Enochian BioSciences, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action – ENOB

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Enochian BioSciences, Inc. (NASDAQ: ENOB) between January 17, 2018 and June 27, 2022, both dates inclusive,...

ENOB : 2.67 (-0.74%)
ENOB Investors Have Opportunity to Lead Enochian Biosciences, Inc. Securities Fraud Lawsuit

/PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action...

ENOB : 2.67 (-0.74%)
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Enochian Investors of a Lead Plaintiff Deadline of September 26, 2022

/PRNewswire/ -- Attention Enochian BioSciences, Inc. ("Enochian") (NASDAQ: ENOB) shareholders: The Law Offices of Vincent Wong announce that a class action...

ENOB : 2.67 (-0.74%)
INVESTOR DEADLINE: Investors in Enochian Biosciences Inc. with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – ENOB

The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Enochian Biosciences Inc. (NASDAQ: ENOB) securities between January 17, 2018 and June 27, 2022, inclusive...

ENOB : 2.67 (-0.74%)
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Enochian BioSciences, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - ENOB

/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Enochian BioSciences, Inc. (NASDAQ: ENOB)...

ENOB : 2.67 (-0.74%)
ENOB SHAREHOLDER ALERT: Jakubowitz Law Reminds Enochian Shareholders of a Lead Plaintiff Deadline of September 26, 2022

/PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Enochian BioSciences, Inc....

ENOB : 2.67 (-0.74%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Enochian BioSciences Inc. engages in the research and development, manufacturing and clinical trials of pharmaceutical and biological products for the human treatment of HIV and cancer. The company's product pipeline consists of ENO-1001, ENO-2001, ENO-3001, ENO-1002, ENO-5001 and ENO-4001. Enochian...

See More

Key Turning Points

3rd Resistance Point 3.10
2nd Resistance Point 2.96
1st Resistance Point 2.82
Last Price 2.67
1st Support Level 2.54
2nd Support Level 2.40
3rd Support Level 2.26

See More

52-Week High 13.78
Fibonacci 61.8% 9.06
Fibonacci 50% 7.60
Fibonacci 38.2% 6.14
Last Price 2.67
52-Week Low 1.42

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar